In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
Israel-based Kitov Pharmaceuticals has appointed Gil Ben-Menachem as vice president business development. 8 January 2016
Biotechnology
Cytos Biotechnology on Friday said the company will be renamed Kuros Biosciences Ltd and that its chief executive Christian Itin will be stepping down from his position. 8 January 2016
Biotechnology
Allogeneic CAR T-cell therapies specialist Cellectis has announced the appointment of Loan Hoang-Sayag to the role of chief medical officer. 8 January 2016
Pharmaceutical
Canadian drug maker Valeant Pharmaceuticals International said it has appointed Howard Schiller as interim chief executive. 7 January 2016
Biotechnology
Genticel on Wednesday named Rémi Palmantier chief scientific officer. 6 January 2016
Pharmaceutical
Shares in Valeant Pharmaceuticals dropped over 10% on December 28 after the company said chief executive Michael Pearson is taking a medical leave with immediate effect. 4 January 2016
Pharmaceutical
British clinical stage drug development company Evgen Pharma has appointed a new chief medical officer, it has been announced. 4 January 2016
Biotechnology
KaloBios Pharmaceuticals, which fired its controversial chief executive Martin Shkreli earlier this month, yesterday announced that, on December 28, 2015, the company submitted a request to Nasdaq requesting an appeal of Nasdaq's decision to delist the company's securities. 30 December 2015
Pharmaceutical
US drugmaker MannKind Corp today announced the appointment of Duane DeSisto as its president and chief executive, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015. 24 December 2015
Biotechnology
Dutch human gene therapy specialist uniQure NV has named Dan Soland its chief executive officer. He will succeed Jörn Aldag, who will step down from the role he has held since 2009. 21 December 2015
Pharmaceutical
KaloBios Pharmaceuticals Inc on Monday said that Martin Shkreli was terminated as chief executive officer of the and resigned from his position as a member of the board of directors. 21 December 2015
Pharmaceutical
Ariad Pharmaceuticals named Paris Panayiotopoulos president and chief executive officer, effective January 1, 2016. 21 December 2015
Pharmaceutical
Australian drug company Novogen has appointed Dr James Garner as its new chief executive, it has been announced. 10 December 2015
Biotechnology
Life sciences company Avacta has appointed Tony Gardiner as group chief financial officer, it has been announced. 10 December 2015
Pharmaceutical
Kesios Therapeutics, a portfolio company of Imperial Innovations Group which is developing novel therapeutics for the treatment of multiple myeloma and other cancers, has closed a £19.0 million ($28.6 million) Series A funding round from a syndicate of leading venture investors including Innovations, SV Life Sciences and Abingworth. 2 December 2015
Biotechnology
French biotech company TxCell has named five new vice presidents across segments in a bid to strengthen its management team. 1 December 2015
Pharmaceutical
Belgian drug developer Ablynx on Monday named Robert Zeldin chief medical officer (CMO) effective December 1. 30 November 2015
Pharmaceutical
Presage Biosciences said it has in-licensed voruciclib, its first clinical stage drug program. 26 November 2015
Pharmaceutical
Following swiftly on yesterday’s news, KaloBios Pharmaceuticals announced that an investor group led by Martin Shkreli, the founder and chief executive of privately-held Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares, up from 55% previously. 20 November 2015
Biotechnology
British biotech company C4X Discovery Holdings has appointed Dr Clive Dix as executive chairman. 19 November 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze